SlideShare a Scribd company logo
Sebastien Gilbert MD
Associate Professor of Surgery
Chief, Division of Thoracic Surgery
The Ottawa Hospital
University of Ottawa
Uniportal Anatomic Pulmonary
Resection
General Thoracic Surgical Club
Tucson, USA
Mar 10-13, 2016
Disclosures
 None
Outline
Background
Review Technical Aspects
Share Early Experience
Case Videos
Reducing Chest Wall Trauma
Thoracic Operations
Reducing Chest Wall Trauma
Thoracic Operations
Rib Spreading Non-Rib Spreading (VATS)
Reducing Chest Wall Trauma
Thoracic Operations
Rib Spreading
Postero-
lateral
Muscle
sparing,
Anterior,
“French
window”
Non-Rib Spreading (VATS)
Reducing Chest Wall Trauma
Thoracic Operations
Rib Spreading
Postero-
lateral
Muscle
sparing,
Anterior,
“French
window”
Non-Rib Spreading (VATS)
Multi-port Single-port
Reducing Chest Wall Trauma
Thoracic Operations
Rib Spreading
Postero-
lateral
Muscle
sparing,
Anterior,
“French
window”
Non-Rib Spreading (VATS)
Multi-port Single-port
Intercostal
Access
Minimal or No
Intercostal Access
Reducing Chest Wall Trauma
Thoracic Operations
Rib Spreading
Postero-
lateral
Muscle
sparing,
Anterior,
“French
window”
Non-Rib Spreading (VATS)
Multi-port Single-port
Intercostal
Access
Minimal or No
Intercostal Access
Subxyphoid,
Subcostal*,
Cervical*
*May include one 5 mm intercostal port
Reducing Chest Wall Trauma
Thoracic Operations
Rib Spreading
Postero-
lateral
Muscle
sparing,
Anterior,
“French
window”
Non-Rib Spreading (VATS)
Multi-port Single-port
Intercostal
Access
Minimal or No
Intercostal Access
Subxyphoid,
Subcostal*,
Cervical*
*May include one 5 mm intercostal port
Is VATS superior to OPEN?
 Common answer = “Yes”
 Equivalent oncologic outcomes1,3
 Similar chest tube drainage, LOS, pain2
 Similar pneumonia, air leak,
arrhythmia, mortality3
1. Sugi et al. WJS 2000; 24, 27–31
2. Kirby et al. JCTVS 1995;109:997-1002
3. Yan et al. JCO 2009; 27:2553-2562
Transition from OPEN to VATS
 How far have we come?
Limited adoption of VATS lobectomy:
STS data = 28-35%1-2 of cases
ESTS data = 11%3 of cases
Why?
1. Boffa et al. JTCVS 2008; 135:247-54
2. Ceppa et al. Ann Surg 2012; Sep;256(3):487-93
3. Begum et al. JTD 2014; 6 Suppl 2:S203-10
Single-port or Uniportal VATS
 Early publications:
2000: Migliore M
2004: Rocco G
2011: Gonzalez-Rivas D
 Popular topic:
Last 10 years: 1000 cases reported
Last 6 months: >400 cases reported
 Only 3 retrospective comparisons:
n≈200 cases
Early outcomes are similar
Is Multi-port superior to Single-Port?
1. Mu et al. Chin Med J 2015;128:2731-5
2. Shen et al. EJCTS 2016; 49 (suppl 1): i48-i53
3. French et al. Ann Cardiothorac Surg 2016 (in press)
Planning the Transition
 Focus on Patient Safety
 Maintain Surgical Quality
 Preserve/Enhance Educational Experience
Port Placement
Technical Aspects
Posterior axillary
Anterior axillary
Single Port: Anterior Hilar Dissection
Camera Head Controls
at 12 o’clock
Camera Post at 6
o’clock “30o up”Retracting Hand
(Surgeon or Assistant)
Operating Hand
Additional
Operating Hand
(Optional)
Surgeon
Single Port: Posterior Hilar Dissection
Camera Head and Post
at 12 o’clock
“30o down”
Retracting Hand
(Surgeon or Assistant)
Operating Hand
Additional
Operating Hand
(Optional)
Surgeon
Incision Plane
Camera Line of Sight
Instruments
Camera Post facing Surgeon
Incision Plane
Camera Line of Sight
Instruments
Camera Post facing Surgeon
Incision Plane
Camera Line of Sight
Instruments
Camera Post facing Surgeon
Incision Plane
Camera Line of Sight
Instruments
Camera Post away from Surgeon
Ergonomics
Ergonomics
Camera
Instruments
Instruments Camera
VATS (n=50) S-VATS (n=50) p
Gender (M:F) 11:39 15:35 0.362
Median [interquartile range]
University of Ottawa: Early Experience
VATS (n=50) S-VATS (n=50) p
Gender (M:F) 11:39 15:35 0.362
Age (years) 67 67 0.820
Median [interquartile range]
University of Ottawa: Early Experience
VATS (n=50) S-VATS (n=50) p
Gender (M:F) 11:39 15:35 0.362
Age (years) 67 67 0.820
BMI 27 [24-30] 27 [22-30] 0.844
Median [interquartile range]
University of Ottawa: Early Experience
VATS (n=50) S-VATS (n=50) p
Gender (M:F) 11:39 15:35 0.362
Age (years) 67 67 0.820
BMI 27 [24-30] 27 [22-30] 0.844
Smokers 38 (76%) 38 (76%) 1.000
Median [interquartile range]
University of Ottawa: Early Experience
VATS (n=50) S-VATS (n=50) p
Gender (M:F) 11:39 15:35 0.362
Age (years) 67 67 0.820
BMI 27 [24-30] 27 [22-30] 0.844
Smokers 38 (76%) 38 (76%) 1.000
Charlson Score 2 [1-3] 2 [1-3] 0.615
Median [interquartile range]
University of Ottawa: Early Experience
VATS (n=50) S-VATS (n=50) p
Gender (M:F) 11:39 15:35 0.362
Age (years) 67 67 0.820
BMI 27 [24-30] 27 [22-30] 0.844
Smokers 38 (76%) 38 (76%) 1.000
Charlson Score 2 [1-3] 2 [1-3] 0.615
FEV1% 85 [69-101] 79 [69-89] 0.072
Median [interquartile range]
University of Ottawa: Early Experience
VATS (n=50) S-VATS (n=50) p
Gender (M:F) 11:39 15:35 0.362
Age (years) 67 67 0.820
BMI 27 [24-30] 27 [22-30] 0.844
Smokers 38 (76%) 38 (76%) 1.000
Charlson Score 2 [1-3] 2 [1-3] 0.615
FEV1% 85 [69-101] 79 [69-89] 0.072
DLCO% 74 [63-85] 73 [64-81] 0.958
Median [interquartile range]
University of Ottawa: Early Experience
VATS (n=50) S-VATS (n=50) p
Gender (M:F) 11:39 15:35 0.362
Age (years) 67 67 0.820
BMI 27 [24-30] 27 [22-30] 0.844
Smokers 38 (76%) 38 (76%) 1.000
Charlson Score 2 [1-3] 2 [1-3] 0.615
FEV1% 85 [69-101] 79 [69-89] 0.072
DLCO% 74 [63-85] 73 [64-81] 0.958
Tumor Size (cm) 2.8 [1.8-3.8] 2.5 [1.6-3.5] 0.332
Median [interquartile range]
University of Ottawa: Early Experience
Operations Performed
Operations VATS (n=50) S-VATS (n=50) p
Lobectomy 42 (84%) 39 (78%) 0.764
Operations Performed
Operations VATS (n=50) S-VATS (n=50) p
Lobectomy 42 (84%) 39 (78%) 0.764
Bilobectomy 0 1 (2%)
Operations Performed
Operations VATS (n=50) S-VATS (n=50) p
Lobectomy 42 (84%) 39 (78%) 0.764
Bilobectomy 0 1 (2%)
Segmentectomy 8 (16%) 10 (20%) 0.603
Operations Performed
Operations VATS (n=50) S-VATS (n=50) p
Lobectomy 42 (84%) 39 (78%) 0.764
Bilobectomy 0 1 (2%)
Segmentectomy 8 (16%) 10 (20%) 0.603
Laterality (right:left) 23:27 26:24 0.548
Intraoperative Outcomes
Outcome VATS (n=50) S-VATS (n=50) p
R0 Resection 50 (100%) 50 (100%) 1.000
Intraoperative Outcomes
Outcome VATS (n=50) S-VATS (n=50) p
R0 Resection 50 (100%) 50 (100%) 1.000
Conversion to Open 1 (2%) 2 (4%) 0.558
Intraoperative Outcomes
Outcome VATS (n=50) S-VATS (n=50) p
R0 Resection 50 (100%) 50 (100%) 1.000
Conversion to Open 1 (2%) 2 (4%) 0.558
Operating Time (min) 146 [121-178] 154 [142-175] 0.081
Intraoperative Outcomes
Outcome VATS (n=50) S-VATS (n=50) p
R0 Resection 50 (100%) 50 (100%) 1.000
Conversion to Open 1 (2%) 2 (4%) 0.558
Operating Time (min) 146 [121-178] 154 [142-175] 0.081
Staplers 8 [6-10] 9 [8-10] 0.577
Intraoperative Outcomes
Outcome VATS (n=50) S-VATS (n=50) p
R0 Resection 50 (100%) 50 (100%) 1.000
Conversion to Open 1 (2%) 2 (4%) 0.558
Operating Time (min) 146 [121-178] 154 [142-175] 0.081
Staplers 8 [6-10] 9 [8-10] 0.577
Chest Tube(s) 1 2 <0.001
Post-Operative Outcomes
Outcomes VATS (n=50) S-VATS (n=50) p
Chest tube drainage (days) 3 [3-5] 3 [2-5] 0.394
‡Ottawa TMM system (https://ottawatmm.org) Seely AJE et al. Ann Thor Surg 2010;90(3):936-42
Post-Operative Outcomes
Outcomes VATS (n=50) S-VATS (n=50) p
Chest tube drainage (days) 3 [3-5] 3 [2-5] 0.394
LOS (days) 4 [3-7] 4 [3-7] 0.992
‡Ottawa TMM system (https://ottawatmm.org) Seely AJE et al. Ann Thor Surg 2010;90(3):936-42
Post-Operative Outcomes
Outcomes VATS (n=50) S-VATS (n=50) p
Chest tube drainage (days) 3 [3-5] 3 [2-5] 0.394
LOS (days) 4 [3-7] 4 [3-7] 0.992
Complications:‡
None 32 (64%) 30 (60%) 0.680
‡Ottawa TMM system (https://ottawatmm.org) Seely AJE et al. Ann Thor Surg 2010;90(3):936-42
Post-Operative Outcomes
Outcomes VATS (n=50) S-VATS (n=50) p
Chest tube drainage (days) 3 [3-5] 3 [2-5] 0.394
LOS (days) 4 [3-7] 4 [3-7] 0.992
Complications:‡
None 32 (64%) 30 (60%) 0.680
Grade I-II 13 (26%) 9 (18%) 0.334
‡Ottawa TMM system (https://ottawatmm.org) Seely AJE et al. Ann Thor Surg 2010;90(3):936-42
Post-Operative Outcomes
Outcomes VATS (n=50) S-VATS (n=50) p
Chest tube drainage (days) 3 [3-5] 3 [2-5] 0.394
LOS (days) 4 [3-7] 4 [3-7] 0.992
Complications:‡
None 32 (64%) 30 (60%) 0.680
Grade I-II 13 (26%) 9 (18%) 0.334
Grade III 4 (8%) 8 (16%) 0.357
‡Ottawa TMM system (https://ottawatmm.org) Seely AJE et al. Ann Thor Surg 2010;90(3):936-42
Post-Operative Outcomes
Outcomes VATS (n=50) S-VATS (n=50) p
Chest tube drainage (days) 3 [3-5] 3 [2-5] 0.394
LOS (days) 4 [3-7] 4 [3-7] 0.992
Complications:‡
None 32 (64%) 30 (60%) 0.680
Grade I-II 13 (26%) 9 (18%) 0.334
Grade III 4 (8%) 8 (16%) 0.357
Grade IV 1 (2%) 2 (4%) 0.558
‡Ottawa TMM system (https://ottawatmm.org) Seely AJE et al. Ann Thor Surg 2010;90(3):936-42
Post-Operative Pain
Outcomes VATS (n=50) S-VATS (n=50) p
Time on PCA (days) 3 [3-3] 3 [2-3] 0.559
Post-Operative Pain
Outcomes VATS (n=50) S-VATS (n=50) p
Time on PCA (days) 3 [3-3] 3 [2-3] 0.559
Total PCA Dose (mg) 3.4 [2.6-8.0] 5.4 [1.6-8.0] 0.209
Post-Operative Pain
Outcomes VATS (n=50) S-VATS (n=50) p
Time on PCA (days) 3 [3-3] 3 [2-3] 0.559
Total PCA Dose (mg) 3.4 [2.6-8.0] 5.4 [1.6-8.0] 0.209
VAS @ 1 hour 3 [0-4] 1 [0-3] 0.009
Post-Operative Pain
Outcomes VATS (n=50) S-VATS (n=50) p
Time on PCA (days) 3 [3-3] 3 [2-3] 0.559
Total PCA Dose (mg) 3.4 [2.6-8.0] 5.4 [1.6-8.0] 0.209
VAS @ 1 hour 3 [0-4] 1 [0-3] 0.009
VAS @ 24 hours 4 [2-5] 4 [3-5] 0.625
Post-Operative Pain
Outcomes VATS (n=50) S-VATS (n=50) p
Time on PCA (days) 3 [3-3] 3 [2-3] 0.559
Total PCA Dose (mg) 3.4 [2.6-8.0] 5.4 [1.6-8.0] 0.209
VAS @ 1 hour 3 [0-4] 1 [0-3] 0.009
VAS @ 24 hours 4 [2-5] 4 [3-5] 0.625
Satisfied with Pain
Control @ 24 hours
48 (96%) 47 (94%) 0.743
Comparing Approaches
Multiport Single Port
MIS training/experience Important ?
Comparing Approaches
Multiport Single Port
MIS training/experience Important ?
Viewing angle similar to open No Yes
Comparing Approaches
Multiport Single Port
MIS training/experience Important ?
Viewing angle similar to open No Yes
Alignment No Yes
Comparing Approaches
Multiport Single Port
MIS training/experience Important ?
Viewing angle similar to open No Yes
Alignment No Yes
Access incision 4th interspace 5th interspace
Comparing Approaches
Multiport Single Port
MIS training/experience Important ?
Viewing angle similar to open No Yes
Alignment No Yes
Access incision 4th interspace 5th interspace
Articulating staplers Optional Required
Comparing Approaches
Multiport Single Port
MIS training/experience Important ?
Viewing angle similar to open No Yes
Alignment No Yes
Access incision 4th interspace 5th interspace
Articulating staplers Optional Required
Dividing PA before vein Optional Required
Comparing Approaches
Multiport Single Port
MIS training/experience Important ?
Viewing angle similar to open No Yes
Alignment No Yes
Access incision 4th interspace 5th interspace
Articulating staplers Optional Required
Dividing PA before vein Optional Required
Clipping PA Optional Recommended
Comparing Approaches
Multiport Single Port
MIS training/experience Important ?
Viewing angle similar to open No Yes
Alignment No Yes
Access incision 4th interspace 5th interspace
Articulating staplers Optional Required
Dividing PA before vein Optional Required
Clipping PA Optional Recommended
Wound protector Optional Recommended
Comparing Approaches
Multiport Single Port
MIS training/experience Important ?
Viewing angle similar to open No Yes
Alignment No Yes
Access incision 4th interspace 5th interspace
Articulating staplers Optional Required
Dividing PA before vein Optional Required
Clipping PA Optional Recommended
Wound protector Optional Recommended
Special instrumentation Optional Optional
Summary
Multiport Single Port
MIS training/experience Important ?
Viewing angle similar to open No Yes
Alignment No Yes
Access incision 4th interspace 5th interspace
Articulating staplers Optional Required
Dividing PA before vein Optional Required
Clipping PA Optional Recommended
Wound protector Optional Recommended
Special instrumentation Optional Optional
Assistant 1 0-1
Thank You!

More Related Content

Similar to Single port lobectomy gtsc 2016 tucson - v6

Critical care aspects of GI surgery by Professor Lars Lundell
Critical care aspects of GI surgery by Professor Lars LundellCritical care aspects of GI surgery by Professor Lars Lundell
Critical care aspects of GI surgery by Professor Lars Lundell
SMACC Conference
 
14.54 krajcer global experience with tri vascular
14.54 krajcer global experience with tri vascular14.54 krajcer global experience with tri vascular
14.54 krajcer global experience with tri vascular
Salutaria
 
Speiser B - AIMRADIAL 2014 - Nursing workload
Speiser B - AIMRADIAL 2014 - Nursing workloadSpeiser B - AIMRADIAL 2014 - Nursing workload
Bienert I - AIMRADIAL 2015 - Exposure
Bienert I - AIMRADIAL 2015 - ExposureBienert I - AIMRADIAL 2015 - Exposure
Emerging factors predicting outcome after kidney transplantation
Emerging factors predicting outcome after kidney transplantationEmerging factors predicting outcome after kidney transplantation
Emerging factors predicting outcome after kidney transplantation
Maarten Naesens
 
Jolly SS et al
Jolly SS et alJolly SS et al
Rib Fractures in the Elderly (Dr. Francis Ali-Osman)
Rib Fractures in the Elderly (Dr. Francis Ali-Osman)Rib Fractures in the Elderly (Dr. Francis Ali-Osman)
Rib Fractures in the Elderly (Dr. Francis Ali-Osman)
honorhealth
 
Ruzsa Z - AIMRADIAL 2015 - Carotid stenting learning curve
Ruzsa Z - AIMRADIAL 2015 - Carotid stenting learning curveRuzsa Z - AIMRADIAL 2015 - Carotid stenting learning curve
Ruzsa Z - AIMRADIAL 2015 - Carotid stenting learning curve
International Chair on Interventional Cardiology and Transradial Approach
 
malas savs 2015
malas savs 2015malas savs 2015
malas savs 2015
Salutaria
 
Gilchrist IC 201305
Gilchrist IC 201305Gilchrist IC 201305
Does the physical work capacity of subjects with early osteoarthritis of hip ...
Does the physical work capacity of subjects with early osteoarthritis of hip ...Does the physical work capacity of subjects with early osteoarthritis of hip ...
Does the physical work capacity of subjects with early osteoarthritis of hip ...
SaxionZorgWelzijn
 
Seto A - AIMRADIAL 2013 - RAUST trial
Seto A - AIMRADIAL 2013 - RAUST trialSeto A - AIMRADIAL 2013 - RAUST trial
Omer Goktekin - TransradialApproach is Better
Omer Goktekin - TransradialApproach is BetterOmer Goktekin - TransradialApproach is Better
Omer Goktekin - TransradialApproach is Better
Euro CTO Club
 
MATTHIAS HONL SilentHip TM inventor
MATTHIAS HONL SilentHip TM inventorMATTHIAS HONL SilentHip TM inventor
MATTHIAS HONL SilentHip TM inventor
Matthias Honl
 
Saturday 1050 – tsuchikane – try to stay intimal
Saturday 1050 – tsuchikane – try to stay intimalSaturday 1050 – tsuchikane – try to stay intimal
Saturday 1050 – tsuchikane – try to stay intimal
Euro CTO Club
 
Kshivets O. Cardioesophageal Cancer Surgery
Kshivets O. Cardioesophageal Cancer SurgeryKshivets O. Cardioesophageal Cancer Surgery
Kshivets O. Cardioesophageal Cancer Surgery
Oleg Kshivets
 
Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion
 Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion
Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion
International Chair on Interventional Cardiology and Transradial Approach
 
Clinical Database
Clinical DatabaseClinical Database
Clinical Database
Robert Chen
 
03 Wainstein aimradial20170922 Compression device
03 Wainstein aimradial20170922 Compression device03 Wainstein aimradial20170922 Compression device
03 Wainstein aimradial20170922 Compression device
International Chair on Interventional Cardiology and Transradial Approach
 
Erik Witvrouw - Hamstring Injuries
Erik Witvrouw - Hamstring InjuriesErik Witvrouw - Hamstring Injuries
Erik Witvrouw - Hamstring Injuries
MuscleTech Network
 

Similar to Single port lobectomy gtsc 2016 tucson - v6 (20)

Critical care aspects of GI surgery by Professor Lars Lundell
Critical care aspects of GI surgery by Professor Lars LundellCritical care aspects of GI surgery by Professor Lars Lundell
Critical care aspects of GI surgery by Professor Lars Lundell
 
14.54 krajcer global experience with tri vascular
14.54 krajcer global experience with tri vascular14.54 krajcer global experience with tri vascular
14.54 krajcer global experience with tri vascular
 
Speiser B - AIMRADIAL 2014 - Nursing workload
Speiser B - AIMRADIAL 2014 - Nursing workloadSpeiser B - AIMRADIAL 2014 - Nursing workload
Speiser B - AIMRADIAL 2014 - Nursing workload
 
Bienert I - AIMRADIAL 2015 - Exposure
Bienert I - AIMRADIAL 2015 - ExposureBienert I - AIMRADIAL 2015 - Exposure
Bienert I - AIMRADIAL 2015 - Exposure
 
Emerging factors predicting outcome after kidney transplantation
Emerging factors predicting outcome after kidney transplantationEmerging factors predicting outcome after kidney transplantation
Emerging factors predicting outcome after kidney transplantation
 
Jolly SS et al
Jolly SS et alJolly SS et al
Jolly SS et al
 
Rib Fractures in the Elderly (Dr. Francis Ali-Osman)
Rib Fractures in the Elderly (Dr. Francis Ali-Osman)Rib Fractures in the Elderly (Dr. Francis Ali-Osman)
Rib Fractures in the Elderly (Dr. Francis Ali-Osman)
 
Ruzsa Z - AIMRADIAL 2015 - Carotid stenting learning curve
Ruzsa Z - AIMRADIAL 2015 - Carotid stenting learning curveRuzsa Z - AIMRADIAL 2015 - Carotid stenting learning curve
Ruzsa Z - AIMRADIAL 2015 - Carotid stenting learning curve
 
malas savs 2015
malas savs 2015malas savs 2015
malas savs 2015
 
Gilchrist IC 201305
Gilchrist IC 201305Gilchrist IC 201305
Gilchrist IC 201305
 
Does the physical work capacity of subjects with early osteoarthritis of hip ...
Does the physical work capacity of subjects with early osteoarthritis of hip ...Does the physical work capacity of subjects with early osteoarthritis of hip ...
Does the physical work capacity of subjects with early osteoarthritis of hip ...
 
Seto A - AIMRADIAL 2013 - RAUST trial
Seto A - AIMRADIAL 2013 - RAUST trialSeto A - AIMRADIAL 2013 - RAUST trial
Seto A - AIMRADIAL 2013 - RAUST trial
 
Omer Goktekin - TransradialApproach is Better
Omer Goktekin - TransradialApproach is BetterOmer Goktekin - TransradialApproach is Better
Omer Goktekin - TransradialApproach is Better
 
MATTHIAS HONL SilentHip TM inventor
MATTHIAS HONL SilentHip TM inventorMATTHIAS HONL SilentHip TM inventor
MATTHIAS HONL SilentHip TM inventor
 
Saturday 1050 – tsuchikane – try to stay intimal
Saturday 1050 – tsuchikane – try to stay intimalSaturday 1050 – tsuchikane – try to stay intimal
Saturday 1050 – tsuchikane – try to stay intimal
 
Kshivets O. Cardioesophageal Cancer Surgery
Kshivets O. Cardioesophageal Cancer SurgeryKshivets O. Cardioesophageal Cancer Surgery
Kshivets O. Cardioesophageal Cancer Surgery
 
Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion
 Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion
Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion
 
Clinical Database
Clinical DatabaseClinical Database
Clinical Database
 
03 Wainstein aimradial20170922 Compression device
03 Wainstein aimradial20170922 Compression device03 Wainstein aimradial20170922 Compression device
03 Wainstein aimradial20170922 Compression device
 
Erik Witvrouw - Hamstring Injuries
Erik Witvrouw - Hamstring InjuriesErik Witvrouw - Hamstring Injuries
Erik Witvrouw - Hamstring Injuries
 

Recently uploaded

NuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyerNuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyer
pablovgd
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
Nistarini College, Purulia (W.B) India
 
Micronuclei test.M.sc.zoology.fisheries.
Micronuclei test.M.sc.zoology.fisheries.Micronuclei test.M.sc.zoology.fisheries.
Micronuclei test.M.sc.zoology.fisheries.
Aditi Bajpai
 
SAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdfSAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdf
KrushnaDarade1
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
moosaasad1975
 
20240520 Planning a Circuit Simulator in JavaScript.pptx
20240520 Planning a Circuit Simulator in JavaScript.pptx20240520 Planning a Circuit Simulator in JavaScript.pptx
20240520 Planning a Circuit Simulator in JavaScript.pptx
Sharon Liu
 
Randomised Optimisation Algorithms in DAPHNE
Randomised Optimisation Algorithms in DAPHNERandomised Optimisation Algorithms in DAPHNE
Randomised Optimisation Algorithms in DAPHNE
University of Maribor
 
Phenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvementPhenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvement
IshaGoswami9
 
The binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defectsThe binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defects
Sérgio Sacani
 
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdfTopic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
TinyAnderson
 
Thornton ESPP slides UK WW Network 4_6_24.pdf
Thornton ESPP slides UK WW Network 4_6_24.pdfThornton ESPP slides UK WW Network 4_6_24.pdf
Thornton ESPP slides UK WW Network 4_6_24.pdf
European Sustainable Phosphorus Platform
 
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxThe use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
MAGOTI ERNEST
 
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptxANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
RASHMI M G
 
Eukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptxEukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptx
RitabrataSarkar3
 
BREEDING METHODS FOR DISEASE RESISTANCE.pptx
BREEDING METHODS FOR DISEASE RESISTANCE.pptxBREEDING METHODS FOR DISEASE RESISTANCE.pptx
BREEDING METHODS FOR DISEASE RESISTANCE.pptx
RASHMI M G
 
Sharlene Leurig - Enabling Onsite Water Use with Net Zero Water
Sharlene Leurig - Enabling Onsite Water Use with Net Zero WaterSharlene Leurig - Enabling Onsite Water Use with Net Zero Water
Sharlene Leurig - Enabling Onsite Water Use with Net Zero Water
Texas Alliance of Groundwater Districts
 
8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf
by6843629
 
aziz sancar nobel prize winner: from mardin to nobel
aziz sancar nobel prize winner: from mardin to nobelaziz sancar nobel prize winner: from mardin to nobel
aziz sancar nobel prize winner: from mardin to nobel
İsa Badur
 
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
Sérgio Sacani
 
Nucleophilic Addition of carbonyl compounds.pptx
Nucleophilic Addition of carbonyl  compounds.pptxNucleophilic Addition of carbonyl  compounds.pptx
Nucleophilic Addition of carbonyl compounds.pptx
SSR02
 

Recently uploaded (20)

NuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyerNuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyer
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
 
Micronuclei test.M.sc.zoology.fisheries.
Micronuclei test.M.sc.zoology.fisheries.Micronuclei test.M.sc.zoology.fisheries.
Micronuclei test.M.sc.zoology.fisheries.
 
SAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdfSAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdf
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
 
20240520 Planning a Circuit Simulator in JavaScript.pptx
20240520 Planning a Circuit Simulator in JavaScript.pptx20240520 Planning a Circuit Simulator in JavaScript.pptx
20240520 Planning a Circuit Simulator in JavaScript.pptx
 
Randomised Optimisation Algorithms in DAPHNE
Randomised Optimisation Algorithms in DAPHNERandomised Optimisation Algorithms in DAPHNE
Randomised Optimisation Algorithms in DAPHNE
 
Phenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvementPhenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvement
 
The binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defectsThe binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defects
 
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdfTopic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
 
Thornton ESPP slides UK WW Network 4_6_24.pdf
Thornton ESPP slides UK WW Network 4_6_24.pdfThornton ESPP slides UK WW Network 4_6_24.pdf
Thornton ESPP slides UK WW Network 4_6_24.pdf
 
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxThe use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
 
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptxANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
 
Eukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptxEukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptx
 
BREEDING METHODS FOR DISEASE RESISTANCE.pptx
BREEDING METHODS FOR DISEASE RESISTANCE.pptxBREEDING METHODS FOR DISEASE RESISTANCE.pptx
BREEDING METHODS FOR DISEASE RESISTANCE.pptx
 
Sharlene Leurig - Enabling Onsite Water Use with Net Zero Water
Sharlene Leurig - Enabling Onsite Water Use with Net Zero WaterSharlene Leurig - Enabling Onsite Water Use with Net Zero Water
Sharlene Leurig - Enabling Onsite Water Use with Net Zero Water
 
8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf
 
aziz sancar nobel prize winner: from mardin to nobel
aziz sancar nobel prize winner: from mardin to nobelaziz sancar nobel prize winner: from mardin to nobel
aziz sancar nobel prize winner: from mardin to nobel
 
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
 
Nucleophilic Addition of carbonyl compounds.pptx
Nucleophilic Addition of carbonyl  compounds.pptxNucleophilic Addition of carbonyl  compounds.pptx
Nucleophilic Addition of carbonyl compounds.pptx
 

Single port lobectomy gtsc 2016 tucson - v6

  • 1. Sebastien Gilbert MD Associate Professor of Surgery Chief, Division of Thoracic Surgery The Ottawa Hospital University of Ottawa Uniportal Anatomic Pulmonary Resection General Thoracic Surgical Club Tucson, USA Mar 10-13, 2016
  • 4. Reducing Chest Wall Trauma Thoracic Operations
  • 5. Reducing Chest Wall Trauma Thoracic Operations Rib Spreading Non-Rib Spreading (VATS)
  • 6. Reducing Chest Wall Trauma Thoracic Operations Rib Spreading Postero- lateral Muscle sparing, Anterior, “French window” Non-Rib Spreading (VATS)
  • 7. Reducing Chest Wall Trauma Thoracic Operations Rib Spreading Postero- lateral Muscle sparing, Anterior, “French window” Non-Rib Spreading (VATS) Multi-port Single-port
  • 8. Reducing Chest Wall Trauma Thoracic Operations Rib Spreading Postero- lateral Muscle sparing, Anterior, “French window” Non-Rib Spreading (VATS) Multi-port Single-port Intercostal Access Minimal or No Intercostal Access
  • 9. Reducing Chest Wall Trauma Thoracic Operations Rib Spreading Postero- lateral Muscle sparing, Anterior, “French window” Non-Rib Spreading (VATS) Multi-port Single-port Intercostal Access Minimal or No Intercostal Access Subxyphoid, Subcostal*, Cervical* *May include one 5 mm intercostal port
  • 10. Reducing Chest Wall Trauma Thoracic Operations Rib Spreading Postero- lateral Muscle sparing, Anterior, “French window” Non-Rib Spreading (VATS) Multi-port Single-port Intercostal Access Minimal or No Intercostal Access Subxyphoid, Subcostal*, Cervical* *May include one 5 mm intercostal port
  • 11. Is VATS superior to OPEN?  Common answer = “Yes”  Equivalent oncologic outcomes1,3  Similar chest tube drainage, LOS, pain2  Similar pneumonia, air leak, arrhythmia, mortality3 1. Sugi et al. WJS 2000; 24, 27–31 2. Kirby et al. JCTVS 1995;109:997-1002 3. Yan et al. JCO 2009; 27:2553-2562
  • 12. Transition from OPEN to VATS  How far have we come? Limited adoption of VATS lobectomy: STS data = 28-35%1-2 of cases ESTS data = 11%3 of cases Why? 1. Boffa et al. JTCVS 2008; 135:247-54 2. Ceppa et al. Ann Surg 2012; Sep;256(3):487-93 3. Begum et al. JTD 2014; 6 Suppl 2:S203-10
  • 13. Single-port or Uniportal VATS  Early publications: 2000: Migliore M 2004: Rocco G 2011: Gonzalez-Rivas D  Popular topic: Last 10 years: 1000 cases reported Last 6 months: >400 cases reported
  • 14.  Only 3 retrospective comparisons: n≈200 cases Early outcomes are similar Is Multi-port superior to Single-Port? 1. Mu et al. Chin Med J 2015;128:2731-5 2. Shen et al. EJCTS 2016; 49 (suppl 1): i48-i53 3. French et al. Ann Cardiothorac Surg 2016 (in press)
  • 15. Planning the Transition  Focus on Patient Safety  Maintain Surgical Quality  Preserve/Enhance Educational Experience
  • 18. Single Port: Anterior Hilar Dissection Camera Head Controls at 12 o’clock Camera Post at 6 o’clock “30o up”Retracting Hand (Surgeon or Assistant) Operating Hand Additional Operating Hand (Optional) Surgeon
  • 19. Single Port: Posterior Hilar Dissection Camera Head and Post at 12 o’clock “30o down” Retracting Hand (Surgeon or Assistant) Operating Hand Additional Operating Hand (Optional) Surgeon
  • 20. Incision Plane Camera Line of Sight Instruments Camera Post facing Surgeon
  • 21. Incision Plane Camera Line of Sight Instruments Camera Post facing Surgeon
  • 22. Incision Plane Camera Line of Sight Instruments Camera Post facing Surgeon
  • 23. Incision Plane Camera Line of Sight Instruments Camera Post away from Surgeon
  • 26. VATS (n=50) S-VATS (n=50) p Gender (M:F) 11:39 15:35 0.362 Median [interquartile range] University of Ottawa: Early Experience
  • 27. VATS (n=50) S-VATS (n=50) p Gender (M:F) 11:39 15:35 0.362 Age (years) 67 67 0.820 Median [interquartile range] University of Ottawa: Early Experience
  • 28. VATS (n=50) S-VATS (n=50) p Gender (M:F) 11:39 15:35 0.362 Age (years) 67 67 0.820 BMI 27 [24-30] 27 [22-30] 0.844 Median [interquartile range] University of Ottawa: Early Experience
  • 29. VATS (n=50) S-VATS (n=50) p Gender (M:F) 11:39 15:35 0.362 Age (years) 67 67 0.820 BMI 27 [24-30] 27 [22-30] 0.844 Smokers 38 (76%) 38 (76%) 1.000 Median [interquartile range] University of Ottawa: Early Experience
  • 30. VATS (n=50) S-VATS (n=50) p Gender (M:F) 11:39 15:35 0.362 Age (years) 67 67 0.820 BMI 27 [24-30] 27 [22-30] 0.844 Smokers 38 (76%) 38 (76%) 1.000 Charlson Score 2 [1-3] 2 [1-3] 0.615 Median [interquartile range] University of Ottawa: Early Experience
  • 31. VATS (n=50) S-VATS (n=50) p Gender (M:F) 11:39 15:35 0.362 Age (years) 67 67 0.820 BMI 27 [24-30] 27 [22-30] 0.844 Smokers 38 (76%) 38 (76%) 1.000 Charlson Score 2 [1-3] 2 [1-3] 0.615 FEV1% 85 [69-101] 79 [69-89] 0.072 Median [interquartile range] University of Ottawa: Early Experience
  • 32. VATS (n=50) S-VATS (n=50) p Gender (M:F) 11:39 15:35 0.362 Age (years) 67 67 0.820 BMI 27 [24-30] 27 [22-30] 0.844 Smokers 38 (76%) 38 (76%) 1.000 Charlson Score 2 [1-3] 2 [1-3] 0.615 FEV1% 85 [69-101] 79 [69-89] 0.072 DLCO% 74 [63-85] 73 [64-81] 0.958 Median [interquartile range] University of Ottawa: Early Experience
  • 33. VATS (n=50) S-VATS (n=50) p Gender (M:F) 11:39 15:35 0.362 Age (years) 67 67 0.820 BMI 27 [24-30] 27 [22-30] 0.844 Smokers 38 (76%) 38 (76%) 1.000 Charlson Score 2 [1-3] 2 [1-3] 0.615 FEV1% 85 [69-101] 79 [69-89] 0.072 DLCO% 74 [63-85] 73 [64-81] 0.958 Tumor Size (cm) 2.8 [1.8-3.8] 2.5 [1.6-3.5] 0.332 Median [interquartile range] University of Ottawa: Early Experience
  • 34. Operations Performed Operations VATS (n=50) S-VATS (n=50) p Lobectomy 42 (84%) 39 (78%) 0.764
  • 35. Operations Performed Operations VATS (n=50) S-VATS (n=50) p Lobectomy 42 (84%) 39 (78%) 0.764 Bilobectomy 0 1 (2%)
  • 36. Operations Performed Operations VATS (n=50) S-VATS (n=50) p Lobectomy 42 (84%) 39 (78%) 0.764 Bilobectomy 0 1 (2%) Segmentectomy 8 (16%) 10 (20%) 0.603
  • 37. Operations Performed Operations VATS (n=50) S-VATS (n=50) p Lobectomy 42 (84%) 39 (78%) 0.764 Bilobectomy 0 1 (2%) Segmentectomy 8 (16%) 10 (20%) 0.603 Laterality (right:left) 23:27 26:24 0.548
  • 38. Intraoperative Outcomes Outcome VATS (n=50) S-VATS (n=50) p R0 Resection 50 (100%) 50 (100%) 1.000
  • 39. Intraoperative Outcomes Outcome VATS (n=50) S-VATS (n=50) p R0 Resection 50 (100%) 50 (100%) 1.000 Conversion to Open 1 (2%) 2 (4%) 0.558
  • 40. Intraoperative Outcomes Outcome VATS (n=50) S-VATS (n=50) p R0 Resection 50 (100%) 50 (100%) 1.000 Conversion to Open 1 (2%) 2 (4%) 0.558 Operating Time (min) 146 [121-178] 154 [142-175] 0.081
  • 41. Intraoperative Outcomes Outcome VATS (n=50) S-VATS (n=50) p R0 Resection 50 (100%) 50 (100%) 1.000 Conversion to Open 1 (2%) 2 (4%) 0.558 Operating Time (min) 146 [121-178] 154 [142-175] 0.081 Staplers 8 [6-10] 9 [8-10] 0.577
  • 42. Intraoperative Outcomes Outcome VATS (n=50) S-VATS (n=50) p R0 Resection 50 (100%) 50 (100%) 1.000 Conversion to Open 1 (2%) 2 (4%) 0.558 Operating Time (min) 146 [121-178] 154 [142-175] 0.081 Staplers 8 [6-10] 9 [8-10] 0.577 Chest Tube(s) 1 2 <0.001
  • 43. Post-Operative Outcomes Outcomes VATS (n=50) S-VATS (n=50) p Chest tube drainage (days) 3 [3-5] 3 [2-5] 0.394 ‡Ottawa TMM system (https://ottawatmm.org) Seely AJE et al. Ann Thor Surg 2010;90(3):936-42
  • 44. Post-Operative Outcomes Outcomes VATS (n=50) S-VATS (n=50) p Chest tube drainage (days) 3 [3-5] 3 [2-5] 0.394 LOS (days) 4 [3-7] 4 [3-7] 0.992 ‡Ottawa TMM system (https://ottawatmm.org) Seely AJE et al. Ann Thor Surg 2010;90(3):936-42
  • 45. Post-Operative Outcomes Outcomes VATS (n=50) S-VATS (n=50) p Chest tube drainage (days) 3 [3-5] 3 [2-5] 0.394 LOS (days) 4 [3-7] 4 [3-7] 0.992 Complications:‡ None 32 (64%) 30 (60%) 0.680 ‡Ottawa TMM system (https://ottawatmm.org) Seely AJE et al. Ann Thor Surg 2010;90(3):936-42
  • 46. Post-Operative Outcomes Outcomes VATS (n=50) S-VATS (n=50) p Chest tube drainage (days) 3 [3-5] 3 [2-5] 0.394 LOS (days) 4 [3-7] 4 [3-7] 0.992 Complications:‡ None 32 (64%) 30 (60%) 0.680 Grade I-II 13 (26%) 9 (18%) 0.334 ‡Ottawa TMM system (https://ottawatmm.org) Seely AJE et al. Ann Thor Surg 2010;90(3):936-42
  • 47. Post-Operative Outcomes Outcomes VATS (n=50) S-VATS (n=50) p Chest tube drainage (days) 3 [3-5] 3 [2-5] 0.394 LOS (days) 4 [3-7] 4 [3-7] 0.992 Complications:‡ None 32 (64%) 30 (60%) 0.680 Grade I-II 13 (26%) 9 (18%) 0.334 Grade III 4 (8%) 8 (16%) 0.357 ‡Ottawa TMM system (https://ottawatmm.org) Seely AJE et al. Ann Thor Surg 2010;90(3):936-42
  • 48. Post-Operative Outcomes Outcomes VATS (n=50) S-VATS (n=50) p Chest tube drainage (days) 3 [3-5] 3 [2-5] 0.394 LOS (days) 4 [3-7] 4 [3-7] 0.992 Complications:‡ None 32 (64%) 30 (60%) 0.680 Grade I-II 13 (26%) 9 (18%) 0.334 Grade III 4 (8%) 8 (16%) 0.357 Grade IV 1 (2%) 2 (4%) 0.558 ‡Ottawa TMM system (https://ottawatmm.org) Seely AJE et al. Ann Thor Surg 2010;90(3):936-42
  • 49. Post-Operative Pain Outcomes VATS (n=50) S-VATS (n=50) p Time on PCA (days) 3 [3-3] 3 [2-3] 0.559
  • 50. Post-Operative Pain Outcomes VATS (n=50) S-VATS (n=50) p Time on PCA (days) 3 [3-3] 3 [2-3] 0.559 Total PCA Dose (mg) 3.4 [2.6-8.0] 5.4 [1.6-8.0] 0.209
  • 51. Post-Operative Pain Outcomes VATS (n=50) S-VATS (n=50) p Time on PCA (days) 3 [3-3] 3 [2-3] 0.559 Total PCA Dose (mg) 3.4 [2.6-8.0] 5.4 [1.6-8.0] 0.209 VAS @ 1 hour 3 [0-4] 1 [0-3] 0.009
  • 52. Post-Operative Pain Outcomes VATS (n=50) S-VATS (n=50) p Time on PCA (days) 3 [3-3] 3 [2-3] 0.559 Total PCA Dose (mg) 3.4 [2.6-8.0] 5.4 [1.6-8.0] 0.209 VAS @ 1 hour 3 [0-4] 1 [0-3] 0.009 VAS @ 24 hours 4 [2-5] 4 [3-5] 0.625
  • 53. Post-Operative Pain Outcomes VATS (n=50) S-VATS (n=50) p Time on PCA (days) 3 [3-3] 3 [2-3] 0.559 Total PCA Dose (mg) 3.4 [2.6-8.0] 5.4 [1.6-8.0] 0.209 VAS @ 1 hour 3 [0-4] 1 [0-3] 0.009 VAS @ 24 hours 4 [2-5] 4 [3-5] 0.625 Satisfied with Pain Control @ 24 hours 48 (96%) 47 (94%) 0.743
  • 54. Comparing Approaches Multiport Single Port MIS training/experience Important ?
  • 55. Comparing Approaches Multiport Single Port MIS training/experience Important ? Viewing angle similar to open No Yes
  • 56. Comparing Approaches Multiport Single Port MIS training/experience Important ? Viewing angle similar to open No Yes Alignment No Yes
  • 57. Comparing Approaches Multiport Single Port MIS training/experience Important ? Viewing angle similar to open No Yes Alignment No Yes Access incision 4th interspace 5th interspace
  • 58. Comparing Approaches Multiport Single Port MIS training/experience Important ? Viewing angle similar to open No Yes Alignment No Yes Access incision 4th interspace 5th interspace Articulating staplers Optional Required
  • 59. Comparing Approaches Multiport Single Port MIS training/experience Important ? Viewing angle similar to open No Yes Alignment No Yes Access incision 4th interspace 5th interspace Articulating staplers Optional Required Dividing PA before vein Optional Required
  • 60. Comparing Approaches Multiport Single Port MIS training/experience Important ? Viewing angle similar to open No Yes Alignment No Yes Access incision 4th interspace 5th interspace Articulating staplers Optional Required Dividing PA before vein Optional Required Clipping PA Optional Recommended
  • 61. Comparing Approaches Multiport Single Port MIS training/experience Important ? Viewing angle similar to open No Yes Alignment No Yes Access incision 4th interspace 5th interspace Articulating staplers Optional Required Dividing PA before vein Optional Required Clipping PA Optional Recommended Wound protector Optional Recommended
  • 62. Comparing Approaches Multiport Single Port MIS training/experience Important ? Viewing angle similar to open No Yes Alignment No Yes Access incision 4th interspace 5th interspace Articulating staplers Optional Required Dividing PA before vein Optional Required Clipping PA Optional Recommended Wound protector Optional Recommended Special instrumentation Optional Optional
  • 63. Summary Multiport Single Port MIS training/experience Important ? Viewing angle similar to open No Yes Alignment No Yes Access incision 4th interspace 5th interspace Articulating staplers Optional Required Dividing PA before vein Optional Required Clipping PA Optional Recommended Wound protector Optional Recommended Special instrumentation Optional Optional Assistant 1 0-1